Form 4: SHW CFO Granted 16,920 Stock Options

Sentiment:

Insider Transaction Report


Sherwin-Williams' SVP of Finance and CFO, Allen J. Mistysyn, was granted 16,920 employee stock options with an exercise price of $331.37.

Summary

  • Allen J. Mistysyn, SVP Finance & CFO of Sherwin-Williams Co. (SHW), was granted 16,920 employee stock options.
  • The options have an exercise price of $331.37 per share.
  • The grant date for these options was October 20, 2025.
  • The options will vest annually in three substantially equal installments, commencing on October 20, 2026.
  • The expiration date for these options is October 19, 2035.
  • The grant was made pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan.

Sentiment

Score: 6

Explanation: Slightly positive due to the alignment of management and shareholder interests through equity compensation, which is a standard and expected practice.

Positives

  • Aligns the interests of the SVP Finance & CFO with those of shareholders, as the value of the options increases with the company's stock price.
  • Serves as a key component of executive compensation, aiding in the retention and motivation of senior management.

Negatives

  • Potential for future dilution of existing shares if the options are exercised, though the impact from this specific grant of 16,920 shares is likely minimal.

Risks

  • No specific risks were detailed in this Form 4 filing.

Future Outlook

The granted stock options will vest annually in three substantially equal installments, commencing on October 20, 2026, and will expire on October 19, 2035, subject to vesting conditions.

Industry Context

The grant of stock options is a common practice in executive compensation across various industries, including the paints and coatings sector, to incentivize performance and align management's financial interests with shareholder value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in publicly traded companies, including peers in the specialty chemicals and coatings industry such as PPG Industries (PPG) and AkzoNobel. The specific number of options and exercise price are typically determined by compensation committees based on performance, role, and market benchmarks, though specific comparable grants are not detailed in this filing.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UtilizationThe options were granted pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan.10/20/2025Indicates adherence to established corporate governance frameworks for executive remuneration and utilization of a pre-approved equity incentive plan.

Stakeholder Impact

  • Shareholders: Potential for future minor dilution if options are exercised, but also benefits from increased alignment of executive incentives with company performance.
  • Employees (specifically the CFO): Receives significant equity compensation, enhancing motivation and retention.

Next Steps

  • The stock options will begin to vest annually in three substantially equal installments starting October 20, 2026.

Key Dates

DateDescription
10/20/2025Date of earliest transaction (grant date of employee stock options).
10/22/2025Date the Form 4 was signed by the attorney-in-fact.
10/20/2026Commencement date for the annual vesting of the stock options.
10/19/2035Expiration date of the employee stock options.

Keywords

Sherwin-Williams, SHW, Stock Options, Executive Compensation, Insider Transaction, Form 4, Allen J. Mistysyn, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.